Articles

Podcasts

Videos

RESPIRATORY INFECTIONS

The Merck combination antibiotic has been previously approved for cUTIs and complicated intra-abdominal infections.

FDA Approves Imipenem-Cilastatin and Relebactam for HABP/VABP

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, shares takeaways from her presentation on combination therapy for gram-negative agents at the 2018 SIDP Annual Meeting.

The Benefits of Dual Therapy for Gram-Negative Infections: An Assessment of the Guidelines

A new study challenges common misconceptions associated with cases of non-ventilator hospital-acquired pneumonia, emphasizing the need for a broader use of preventive measures.

Non-ventilator Hospital-acquired Pneumonia: An Emerging Threat

Lucy B. Palmer, MD, from Stony Brook University School of Medicine in New York argues that inhaled antibiotic therapy provides higher drug concentrations of antibiotics with fewer systemic side effects than IV therapy.

Is it Time to Give Inhaled Antibiotics Another Chance?

Reducing overall antibiotic exposure is likely to have an impact on decreasing antimicrobial resistance.

Antimicrobial Stewardship in HAP / VAP: A Focus on Duration of Therapy

Contagion® Editorial Advisory Board member, Khalid Eljaaly, PharmD, BCPS, CAPP, discusses key updates in the Infectious Diseases Society of America and the American Thoracic Society recommendations.

Changes in Therapy Guideline for Nosocomial Pneumonia

In case you missed them, our top 5 articles for the week of March 12, 2017 are highlighted here.

Top 5 Contagion® News Articles for the Week of March 12, 2017

Dental plaque may be a culprit in the development of pneumonia, but better oral health can mitigate that risk both in ventilated hospital patients and in healthy individuals.

Dental Plaque May Provide a Pathway to Pneumonia in Ventilated Patients

Guideline Updates for Infective Endocarditis, HAP, and VAP

Grace Lee, MD, MPH, associate medical director, Infection Control, Boston Children’s Hospital, discusses the current VAP bundle and its focus on infectious conditions as well as the need for a VAC bundle that will prevent other causes of VAC for patients on the ventilator.